Supernus Pharmaceuticals Inc. (SUPN)
NASDAQ · Healthcare
Supernus Pharmaceuticals Inc. Long Term Debt 2010–2025
Supernus Pharmaceuticals Inc. annual/quarterly long term debt history from 2012 to 2021. Long term debt refers to financial obligations that are due more than one year in the future.
- Supernus Pharmaceuticals Inc. long term debt for the quarter ending December 31, 2021 were 379.3M, a 1532.95% increase year-over-year.
- Supernus Pharmaceuticals Inc. long term debt for 2021 were 379.3M, a 1532.95% increase from 2012.
- Supernus Pharmaceuticals Inc. long term debt for 2012 were 23.2M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Supernus Pharmaceuticals Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2021 | $379 |
| 2012 | $23 |
| Supernus Pharmaceuticals Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2021-12-31 | $379 |
| 2012-12-31 | $23 |
Supernus Pharmaceuticals Inc. Long Term Debt — FAQ
Supernus Pharmaceuticals Inc. (SUPN) long term debt over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SUPN's long term debt history?
The chart and table above show Supernus Pharmaceuticals Inc.'s long term debt by year and by quarter, including the growth rate.